FierceBiotech16 小时
Denali eyes approval after Hunter syndrome drug clears safety measures, reduces biomarkers ...
After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the ...
Second Clinical Trial Getting Underway for PathMaker’s Non-Invasive ALS Treatment PlatformBOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (“PathMaker”), a clinical-stage neuromodulation company developing ...